Income Statement China Life Insurance Company Limited

Equities

2628

CNE1000002L3

Life & Health Insurance

Market Closed - Hong Kong S.E. Other stock markets 03:09:08 2025-12-05 EST			5-day change	1st Jan Change
28.22 ^HKD	+5.46%		+5.06%	+92.23%

10-31	Corporate earnings calendar for October 31, 2025: Intesa, Spie, and Scor, with Exxon Mobil still to come
10-30	China Life Insurance Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2025	CI

83e281c.JmWJAlT2EmTUach_9oyKnWcdknwSxl_iY-5qFIbXKus.bx2-UHmOfwC7GLEIrum57ilL5k1Rl2-SVJ5ZQMSHEqpUBLt3Ho4jFK08vw

Published financial data: CHINA LIFE INSURANCE COMPANY LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Premiums and Annuity Revenues	571B	570B	571B	583B	203B
Total Interest And Dividend Income	104B	116B	214B	117B	-30.02B
Gain (Loss) on Sale of Investments, Total (Rev)	86.47B	88.95B	-31.58B	14.76B	118B
Other Revenues, Total	17.42B	19.97B	12.6B	19.61B	22.92B
Total Revenues	779B	795B	766B	735B	314B
Policy Benefits	576B	604B	616B	586B	175B
Policy Acquisition / Underwriting Costs, Total	84.34B	65.74B	54.78B	63.09B	1.8B
Selling General & Admin Expenses, Total	38.92B	42.06B	41.19B	40.35B	7.38B
Provision for Bad Debts	-	-	-	-	-
Provision For Loan Losses - (Ins. / REIT / Utility Templates)	275M	-1.38B	1.48B	1.51B	-
Other Operating Expenses	9.17B	13.81B	31.65B	16.68B	8.74B
Total Operating Expenses	708B	727B	742B	705B	193B
Operating Income	70.89B	68.01B	24.19B	29.8B	121B
Interest Expense, Total	-16.12B	-17.83B	-	-17.32B	-4.2B
Currency Exchange Gains (Loss)	119M	645M	-69M	-381M	-25M
Other Non Operating Income (Expenses)	-	87M	61M	71M	-82M
EBT, Excl. Unusual Items	54.89B	50.91B	24.18B	12.17B	117B
Gain (Loss) on Sale of Assets	24M	69M	122M	73M	88M
Asset Writedown	-83M	-88M	-36M	-71M	-1.61B
Other Unusual Items	-342M	-398M	-221M	-290M	-387M
EBT, Incl. Unusual Items	54.49B	50.5B	24.05B	11.88B	115B
Income Tax Expense	3.1B	-1.92B	-9.47B	-10.76B	6.27B
Earnings From Continuing Operations	51.38B	52.41B	33.51B	22.63B	109B
Net Income to Company	51.38B	52.41B	33.51B	22.63B	109B
Minority Interest	-1.12B	-1.49B	-1.43B	-1.52B	-2B
Net Income - (IS)	50.27B	50.92B	32.08B	21.11B	107B
Preferred Dividend and Other Adjustments	201M	-	-	-	-
Net Income to Common Incl Extra Items	50.07B	50.92B	32.08B	21.11B	107B
Net Income to Common Excl. Extra Items	50.07B	50.92B	32.08B	21.11B	107B
Per Share Items
Net EPS - Basic	1.77	1.8	1.14	0.75	3.78
Basic EPS - Continuing Operations	1.77	1.8	1.14	0.75	3.78
Basic Weighted Average Shares Outstanding	28.26B	28.26B	28.26B	28.26B	28.26B
Net EPS - Diluted	1.77	1.8	1.14	0.75	3.78
Diluted EPS - Continuing Operations	1.77	1.8	1.14	0.75	3.78
Diluted Weighted Average Shares Outstanding	28.26B	28.26B	28.26B	28.26B	28.26B
Normalized Basic EPS	1.17	1.07	0.48	0.22	2.52
Normalized Diluted EPS	1.17	1.07	0.48	0.22	2.52
Dividend Per Share	0.64	0.65	0.49	0.43	0.65
Payout Ratio	49.28	52.35	82.25	105.11	25.17
American Depositary Receipts Ratio (ADR)	5	5	5	5	5
Supplemental Items
EBITDA	74.12B	71.5B	27.98B	33.62B	126B
EBITA	71.22B	68.35B	24.55B	30.18B	122B
EBIT	70.89B	68.01B	24.19B	29.8B	121B
EBITDAR	74.63B	72.08B	28.89B	34.2B	126B
Effective Tax Rate - (Ratio)	5.69	-3.8	-39.37	-90.55	5.44
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	6.59B	4.82B	2.19B	1.24B	1.57B
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-3.48B	-6.74B	-11.66B	-12B	4.71B
Normalized Net Income	33.19B	30.33B	13.68B	6.08B	71.2B
Interest on Long-Term Debt	1.62B	1.6B	1.57B	1.55B	571M
Supplemental Operating Expense Items
Advertising Expense	2.21B	2.4B	2.47B	2.82B	-
Marketing Expenses	461M	511M	420M	-	-
Selling and Marketing Expenses	2.67B	2.92B	2.89B	2.82B	-
General and Administrative Expenses	-	-	-	36.99B	-
Net Rental Expense, Total	504M	585M	910M	584M	555M
Imputed Operating Lease Interest Expense	366M	352M	-	349M	79.95M
Imputed Operating Lease Depreciation	138M	233M	-	235M	475M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Investment In Debt Securities	1,770B	2,327B	2,454B	2,934B	3,656B
Investment In Equity and Preferred Securities, Total	874B	894B	1,120B	1,293B	474B
Trading Asset Securities, Total	162B	207B	224B	254B	1,908B
Real Estate Owned	14.22B	13.37B	13.19B	12.75B	12.32B
Policy Loans	204B	240B	254B	270B	-
Total Other Investments	553B	540B	522B	420B	468B
Total investments	3,577B	4,221B	4,587B	5,184B	6,518B
Cash And Equivalents	36.23B	55.8B	85.64B	103B	81.6B
Reinsurance Recoverable - (IS)	6.1B	6.63B	7.84B	7.97B	30.74B
Other Receivables - (Insurance Template)	536B	523B	427B	422B	22.01B
Separate Account Assets	10M	9M	7M	8.42B	-
Gross Property Plant And Equipment	76.61B	80.39B	82.31B	83.53B	86.18B
Accumulated Depreciation	-21.76B	-24.24B	-26.42B	-28.75B	-30.96B
Net Property Plant And Equipment	54.85B	56.15B	55.89B	54.77B	55.22B
Other Intangibles, Total	8.34B	8.41B	8.53B	8.37B	8.26B
Restricted Cash	21.37B	5.08B	43.31B	46.43B	4.92B
Other Current Assets, Total	2.8B	3.87B	4.79B	4.63B	759M
Deferred Tax Assets Long-Term (Collected)	87M	121M	22.31B	30.29B	40.03B
Deferred Charges Long-Term	1.06B	822M	525M	473M	441M
Other Long-Term Assets, Total	8.25B	10.58B	9.78B	17.31B	7.7B
Total Assets	4,252B	4,891B	5,252B	5,888B	6,770B
Liabilities
Accrued Expenses, Total	20.27B	19.33B	19.77B	17.11B	11.28B
Insurance And Annuity Liabilities	3,370B	3,844B	4,339B	4,860B	-
Unpaid Claims	77.02B	83.05B	86.97B	91.05B	64.34B
Unearned Premiums	67.72B	62.76B	63.94B	64.04B	5,789B
Reinsurance Payable - (BS)	1.04B	808M	998M	748M	160M
Current Portion of Long-Term Debt	-	794M	3.19B	12.72B	9.47B
Current Portion of Leases	1.27B	1.09B	919M	757M	767M
Short-Term Borrowings	124B	241B	149B	217B	152B
Long-Term Debt	52.91B	51.41B	44.58B	35B	38.42B
Long-Term Leases	1.39B	1.09B	650M	498M	551M
Separate Account Liability	10M	9M	7M	8.42B	-
Current Income Taxes Payable	191M	248M	238M	309M	237M
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	965M	868M	1.27B	1.14B	61.92B
Unearned Revenue Non Current	99M	95M	92M	88M	84M
Pension & Other Post Retirement Benefits	1.32B	1.94B	961M	755M	1.23B
Deferred Tax Liability Non-Current	15.29B	7.48B	272M	1.55B	147M
Other Non Current Liabilities	62.25B	89B	95.37B	108B	119B
Total Liabilities	3,795B	4,404B	4,807B	5,418B	6,248B
Common Stock, Total	28.26B	28.26B	28.26B	28.26B	28.26B
Additional Paid In Capital	53.95B	54.3B	53.55B	53.93B	54.16B
Retained Earnings	313B	346B	359B	367B	559B
Comprehensive Income and Other	54.86B	50.3B	-4.93B	11.39B	-132B
Total Common Equity	450B	479B	436B	460B	510B
Minority Interest	6.88B	8.07B	8.95B	9.93B	11.57B
Total Equity	457B	487B	445B	470B	521B
Total Liabilities And Equity	4,252B	4,891B	5,252B	5,888B	6,770B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	28.26B	28.26B	28.26B	28.26B	28.26B
ECS Total Common Shares Outstanding	28.26B	28.26B	28.26B	28.26B	28.26B
Book Value / Share	15.92	16.93	15.43	16.28	18.03
Tangible Book Value	442B	470B	428B	452B	501B
Tangible Book Value Per Share	15.63	16.63	15.13	15.98	17.74
Total Debt	179B	295B	198B	266B	201B
Net Debt	143B	240B	113B	163B	119B
Debt Equivalent Oper. Leases	4.03B	4.68B	7.28B	4.67B	4.44B
Minority Interest, Total (Incl. Fin. Div)	6.88B	8.07B	8.95B	9.93B	11.57B
Equity Method Investments, Total	240B	258B	261B	258B	302B
Account Code - Inventory Valuation	3	3	3	3	3
Buildings, Total	50.4B	58.57B	62.93B	63.46B	65.03B
Machinery, Total	9.44B	9.66B	10.15B	11.31B	12B
Full Time Employees	104K	103K	102K	100K	98.69K

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	50.27B	50.92B	32.08B	21.11B	107B
Depreciation, Depletion & Amortization	4.42B	4.56B	4.57B	4.38B	4.62B
Amortization of Goodwill and Intangible Assets - (CF)	323M	339M	360M	383M	405M
Total Depreciation, Depletion & Amortization	4.75B	4.9B	4.93B	4.76B	5.03B
Amortization of Deferred Charges, Total	413M	389M	363M	258M	-
(Gain) Loss On Sale of Asset - (CF)	-24M	1.32B	-1.6B	-66M	-84M
(Gain) Loss on Sale of Investments - (CF)	-4.26B	26.84B	32.05B	48.89B	-119B
Total Asset Writedown	12.42B	88M	36M	71M	1.61B
Provision and Write-off of Bad Debts	-	-	-	-	-207M
Change in Trading Asset Securities	-18.95B	-44.53B	-35.29B	-13.78B	-
Change in Accounts Receivable	-1.55B	3.6B	10.47B	3.54B	24M
Change In Deferred Taxes	-3.48B	-6.74B	-11.66B	-12B	4.71B
Change in insurance Reserves / Liabilities	-	-	-	-	580B
Change in Other Net Operating Assets (Collected)	24.14B	22.03B	67.46B	102B	-15.98B
Other Operating Activities	240B	228B	253B	233B	-184B
Cash from Operations	304B	286B	352B	388B	379B
Capital Expenditure	-7.47B	-5.48B	-3.08B	-4.17B	-3.98B
Sale of Property, Plant, and Equipment	57M	341M	363M	1.05B	261M
Cash Acquisitions	-	-35.92B	-34.74B	-34.04B	-13.72B
Divestitures	2.18B	559M	4.4B	-	8.66B
Investment in Marketable and Equity Securities, Total	-418B	-492B	-301B	-566B	-536B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-25.86B	-35.48B	-18.2B	-16.08B	-
Other Investing Activities, Total	156B	174B	188B	191B	190B
Cash from Investing	-293B	-394B	-165B	-428B	-355B
Short Term Debt Issued, Total	4.91B	117B	-	67.13B	-
Long-Term Debt Issued, Total	6.82B	-	688M	43M	35.06B
Total Debt Issued	11.73B	117B	688M	67.17B	35.06B
Short Term Debt Repaid, Total	-	-	-	-	-65.88B
Long-Term Debt Repaid, Total	-7.98B	-1.52B	-100B	-1.73B	-36.21B
Total Debt Repaid	-7.98B	-1.52B	-100B	-1.73B	-102B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-9.06B	-	-	-	-
Common Dividends Paid	-24.77B	-26.66B	-26.39B	-22.19B	-26.92B
Common & Preferred Stock Dividends Paid	-24.77B	-26.66B	-26.39B	-22.19B	-26.92B
Other Financing Activities, Total	22.32B	22.1B	5.9B	17.02B	7.18B
Cash from Financing	-7.76B	111B	-120B	60.27B	-86.76B
Foreign Exchange Rate Adjustments	-144M	-71M	217M	64M	28M
Net Change in Cash	3.32B	3.78B	67.14B	20.47B	-62.56B
Supplemental Items
Cash Interest Paid	9.85B	12.71B	13.34B	-	-
Cash Income Tax Paid (Refund)	8.32B	12.07B	6.22B	5.78B	6.52B
Net Debt Issued / Repaid	3.75B	116B	-99.6B	65.45B	-67.02B
Levered Free Cash Flow	26.77B	-9.5B	-65.77B	-4.98B	-755B
Unlevered Free Cash Flow	36.85B	1.65B	-65.77B	5.85B	-753B
Change In Net Working Capital	5.15B	40.67B	83.1B	13.62B	830B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	1.11	0.93	0.3	0.33	1.22
Return on Total Capital	7.25	5.99	2.12	2.7	11.45
Return On Equity %	11.86	11.11	7.19	4.95	25.37
Return on Common Equity	11.73	10.97	7.01	4.71	25.54
Margin Analysis
Gross Profit Margin %	15.25	15.56	12.64	11.79	43.74
SG&A Margin	4.97	5.26	5.35	5.46	2.35
EBITDA Margin %	9.52	9	3.65	4.57	39.93
EBITA Margin %	9.14	8.6	3.21	4.11	38.75
EBIT Margin %	9.1	8.56	3.16	4.06	38.62
Income From Continuing Operations Margin %	6.6	6.6	4.38	3.08	34.65
Net Income Margin %	6.45	6.41	4.19	2.87	34.01
Net Avail. For Common Margin %	6.43	6.41	4.19	2.87	34.01
Normalized Net Income Margin	4.26	3.82	1.79	0.83	22.64
Levered Free Cash Flow Margin	3.44	-1.19	-8.59	-0.68	-240.26
Unlevered Free Cash Flow Margin	4.73	0.21	-8.59	0.8	-239.43
Asset Turnover
Asset Turnover	0.2	0.17	0.15	0.13	0.05
Fixed Assets Turnover	14.28	14.32	13.52	13.28	5.72
Receivables Turnover (Average Receivables)	35.51	33.38	39.19	33.99	-
Short Term Liquidity
Current Ratio	0.59	0.58	0.88	0.82	0.34
Quick Ratio	0.45	0.48	0.69	0.66	0.33
Operating Cash Flow to Current Liabilities	0.59	0.44	0.65	0.62	0.06
Days Sales Outstanding (Average Receivables)	10.31	10.94	9.31	10.74	-
Average Days Payable Outstanding	160.47	168.6	169.2	172.38	131.17
Long Term Solvency
Total Debt/Equity	39.28	60.68	44.55	56.52	38.53
Total Debt / Total Capital	28.2	37.76	30.82	36.11	27.81
LT Debt/Equity	11.88	10.79	10.16	7.55	7.48
Long-Term Debt / Total Capital	8.53	6.71	7.03	4.82	5.4
Total Liabilities / Total Assets	89.25	90.05	91.52	92.02	92.3
EBIT / Interest Expense	4.4	3.81	-	1.72	28.91
EBITDA / Interest Expense	4.69	4.09	-	1.99	30.11
(EBITDA - Capex) / Interest Expense	4.23	3.78	-	1.75	29.16
Total Debt / EBITDA	2.37	4.05	6.81	7.69	1.59
Net Debt / EBITDA	1.89	3.28	3.87	4.7	0.94
Total Debt / (EBITDA - Capex)	2.63	4.38	7.61	8.74	1.64
Net Debt / (EBITDA - Capex)	2.1	3.55	4.33	5.35	0.97
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	13.01	2.03	-3.63	-4.05	43.33
Gross Profit, 1 Yr. Growth %	-4.07	4.14	-21.71	-10.54	87.81
EBITDA, 1 Yr. Growth %	-5.8	0.79	-47.75	-26.25	117.43
EBITA, 1 Yr. Growth %	-6.48	0.47	-51.26	-28.4	131.05
EBIT, 1 Yr. Growth %	-6.52	0.45	-51.64	-28.7	130.29
Earnings From Cont. Operations, 1 Yr. Growth %	-12.93	2.02	-35.87	-32.47	106.69
Net Income, 1 Yr. Growth %	-13.76	1.32	-36.8	-34.2	108.92
Normalized Net Income, 1 Yr. Growth %	-9.93	-8.6	-54.74	-55.56	128.23
Diluted EPS Before Extra, 1 Yr. Growth %	-13.58	1.69	-36.8	-34.2	108.84
Net Property, Plant and Equip., 1 Yr. Growth %	1.12	2.38	-2.62	-1.99	0.82
Accounts Receivable, 1 Yr. Growth %	19.96	-1.78	-3.26	9.26	-
Total Assets, 1 Yr. Growth %	14.11	15.02	7.35	12.12	19.74
Common Equity, 1 Yr. Growth %	11.46	6.34	-8.95	5.49	55.49
Tangible Book Value, 1 Yr. Growth %	11.63	6.44	-9.12	5.64	56.98
Cash From Operations, 1 Yr. Growth %	6.29	-5.78	22.87	10.3	-1.45
Capital Expenditures, 1 Yr. Growth %	-34.59	-26.7	-44.9	35.6	-4.6
Levered Free Cash Flow, 1 Yr. Growth %	-71.82	-135.57	394.6	-92.43	-115.55
Unlevered Free Cash Flow, 1 Yr. Growth %	-64.84	-95.27	394.6	-110.67	-115.5
Dividend Per Share, 1 Yr. Growth %	-12.33	1.56	-24.62	-12.24	51.16
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	22.53	7.38	-0.84	-3.84	15.28
Gross Profit, 2 Yr. CAGR %	27.39	-0.05	-9.7	-16.31	11.94
EBITDA, 2 Yr. CAGR %	51.35	-4.68	-37.2	-20.77	14.65
EBITA, 2 Yr. CAGR %	53.44	-5.26	-39.93	-22.59	15.24
EBIT, 2 Yr. CAGR %	53.78	-5.3	-40.23	-22.82	15.05
Earnings From Cont. Operations, 2 Yr. CAGR %	107.49	-5.76	-19.23	-34.19	26.47
Net Income, 2 Yr. CAGR %	110.03	-6.53	-20.1	-35.52	26.64
Normalized Net Income, 2 Yr. CAGR %	99.37	-9.28	-35.79	-55.15	13.11
Diluted EPS Before Extra, 2 Yr. CAGR %	113.16	-6.26	-19.92	-35.52	26.56
Net Property, Plant and Equip., 2 Yr. CAGR %	8.64	1.75	0.94	-2.3	-0.6
Accounts Receivable, 2 Yr. CAGR %	15.1	8.55	-2.52	2.81	-
Total Assets, 2 Yr. CAGR %	14.31	14.56	11.13	9.71	16.24
Common Equity, 2 Yr. CAGR %	18.9	8.87	-1.55	-2	18
Tangible Book Value, 2 Yr. CAGR %	19.32	9.01	-1.61	-2.02	18.43
Cash From Operations, 2 Yr. CAGR %	43.54	0.07	7.6	16.42	4.74
Capital Expenditures, 2 Yr. CAGR %	-38.19	-30.74	-35.83	-13.57	13.73
Levered Free Cash Flow, 2 Yr. CAGR %	38.49	-68.39	56.96	-38.79	220.23
Unlevered Free Cash Flow, 2 Yr. CAGR %	24.74	-87.46	37.4	-33.7	219.67
Dividend Per Share, 2 Yr. CAGR %	100	-5.64	-12.5	-18.66	15.18
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	11.91	15.27	3.58	-1.92	-26.59
Gross Profit, 3 Yr. CAGR %	6.84	19.11	-7.87	-9.98	3.61
EBITDA, 3 Yr. CAGR %	8.14	30.25	-29.15	-22.04	32.85
EBITA, 3 Yr. CAGR %	7.81	31.23	-31.43	-23.73	34.24
EBIT, 3 Yr. CAGR %	7.81	31.4	-31.68	-23.93	34.39
Earnings From Cont. Operations, 3 Yr. CAGR %	16.2	63.75	-17.19	-23.91	27.75
Net Income, 3 Yr. CAGR %	15.94	64.71	-18.05	-25.11	28.19
Normalized Net Income, 3 Yr. CAGR %	8.88	53.72	-28.12	-43.2	33.04
Diluted EPS Before Extra, 3 Yr. CAGR %	16.22	66.56	-17.86	-25	28.15
Net Property, Plant and Equip., 3 Yr. CAGR %	9.23	6.52	1	-0.04	-1.27
Accounts Receivable, 3 Yr. CAGR %	13.65	9.17	4.46	1.26	-
Total Assets, 3 Yr. CAGR %	13.64	14.55	12.12	11.46	11.43
Common Equity, 3 Yr. CAGR %	11.93	14.55	2.61	0.74	2.09
Tangible Book Value, 3 Yr. CAGR %	11.99	14.86	2.62	0.75	2.14
Cash From Operations, 3 Yr. CAGR %	14.79	24.75	7.16	8.49	9.76
Capital Expenditures, 3 Yr. CAGR %	-8.1	-34.57	-35.41	-17.65	-10.68
Levered Free Cash Flow, 3 Yr. CAGR %	-26.83	-12.05	-11.54	-42.86	284.43
Unlevered Free Cash Flow, 3 Yr. CAGR %	-21.96	-58.86	-14.39	-44.84	283.99
Dividend Per Share, 3 Yr. CAGR %	16.96	59.56	-12.44	-12.42	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	14.11	10.95	6.62	7.21	-14.52
Gross Profit, 5 Yr. CAGR %	6.25	11.64	-0.11	3.43	2.13
EBITDA, 5 Yr. CAGR %	5.95	13.72	-13.75	0.77	9.8
EBITA, 5 Yr. CAGR %	5.75	13.74	-15.45	-0.04	9.85
EBIT, 5 Yr. CAGR %	5.75	13.78	-15.63	-0.12	9.87
Earnings From Cont. Operations, 5 Yr. CAGR %	7.87	21.76	0.46	13.65	13.04
Net Income, 5 Yr. CAGR %	7.69	21.63	-0.11	13.12	12.9
Normalized Net Income, 5 Yr. CAGR %	3.25	15.76	-11.86	-6.14	14.08
Diluted EPS Before Extra, 5 Yr. CAGR %	7.73	22.22	0.13	13.9	13.04
Net Property, Plant and Equip., 5 Yr. CAGR %	15.57	13.43	5.84	3.34	0.36
Accounts Receivable, 5 Yr. CAGR %	11.72	8.69	6.88	6.58	-
Total Assets, 5 Yr. CAGR %	11.67	12.64	12.63	12.59	12.68
Common Equity, 5 Yr. CAGR %	6.89	9.53	6.33	7.64	4.77
Tangible Book Value, 5 Yr. CAGR %	6.91	9.58	6.34	7.8	4.85
Cash From Operations, 5 Yr. CAGR %	74.46	26.31	11.86	21.35	5.78
Capital Expenditures, 5 Yr. CAGR %	-2.29	0.61	-20.39	-26.58	-19
Levered Free Cash Flow, 5 Yr. CAGR %	18.33	-37.01	-0.77	-18.62	51.38
Unlevered Free Cash Flow, 5 Yr. CAGR %	17.04	-54.88	-3.24	-24.41	48.34
Dividend Per Share, 5 Yr. CAGR %	8.79	22.05	4.14	21.86	-2.29